Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryce Chackerian

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Papillomavirus Research (Amsterdam, Netherlands)|July 20, 2017
Characterization of a spray-dried candidate HPV L2-VLP vaccine stored for multiple years at room temperatureJulianne Peabody, Pavan Muttil, Bryce Chackerian, et al.
Current Opinion in Virology|April 2, 2015
Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platformJohn P O'Rourke, David S Peabody, Bryce Chackerian
Current Opinion in Virology|April 5, 2016
Engineering virus-like particles as vaccine platformsKathryn M Frietze, David S Peabody, Bryce Chackerian
Vaccine|May 10, 2011
Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responsesZoe Hunter, Ebenezer Tumban, Agnieszka Dziduszko, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse modelBryce Chackerian, Marisa R Durfee, John T Schiller
Vaccine|June 30, 2006
Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responsesBryce Chackerian, Marisa Rangel, Zoe Hunter, et al.
Vaccine|October 24, 2009
Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccineZoe Hunter, Hugh D Smyth, Paul Durfee, et al.
Vaccine|August 13, 2013
A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvantsEbenezer Tumban, Julianne Peabody, David S Peabody, et al.
Plos One|August 23, 2011
A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2Ebenezer Tumban, Julianne Peabody, David S Peabody, et al.
Biotechnology and Bioengineering|June 12, 2014
The use of hybrid virus-like particles to enhance the immunogenicity of a broadly protective HPV vaccineMitchell Tyler, Ebenezer Tumban, David S Peabody, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Papillomavirus Research (Amsterdam, Netherlands)|July 20, 2017
Characterization of a spray-dried candidate HPV L2-VLP vaccine stored for multiple years at room temperatureJulianne Peabody, Pavan Muttil, Bryce Chackerian, et al.
Current Opinion in Virology|April 2, 2015
Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platformJohn P O'Rourke, David S Peabody, Bryce Chackerian
Current Opinion in Virology|April 5, 2016
Engineering virus-like particles as vaccine platformsKathryn M Frietze, David S Peabody, Bryce Chackerian
Vaccine|May 10, 2011
Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responsesZoe Hunter, Ebenezer Tumban, Agnieszka Dziduszko, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse modelBryce Chackerian, Marisa R Durfee, John T Schiller
Vaccine|June 30, 2006
Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responsesBryce Chackerian, Marisa Rangel, Zoe Hunter, et al.
Vaccine|October 24, 2009
Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccineZoe Hunter, Hugh D Smyth, Paul Durfee, et al.
Vaccine|August 13, 2013
A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvantsEbenezer Tumban, Julianne Peabody, David S Peabody, et al.
Plos One|August 23, 2011
A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2Ebenezer Tumban, Julianne Peabody, David S Peabody, et al.
Biotechnology and Bioengineering|June 12, 2014
The use of hybrid virus-like particles to enhance the immunogenicity of a broadly protective HPV vaccineMitchell Tyler, Ebenezer Tumban, David S Peabody, et al.
Pageof 10